Browsing by Subject "A61P 37/00"
Now showing items 1-7 of 7
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-09-04)The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R1 comprises at least one moiety selected from a group ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-04-10)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-11-06)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-05-08)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-06-19)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-12-29)Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2007-06-12)The present invention provides a compound of Formula I, all of its related stereoisomers, and their pharmaceutically acceptable salts, wherein A—B, K, Q, X, Y, Z, R and R1 are as defined in Claim 1. The present invention ...